Abstract: This invention relates to identification of a new key marker, namely, 9-O-Acetylated Sialoglycoconjugate with the help of a known 9-O-Acetylsialic acid binding lectin, AchatininH useful for the detection of minimal residual disease (MRD) and prediction of relapse by a lymphoproliferation assay in acute lymphoblastic leukaemia (ALL).
Type:
Grant
Filed:
March 26, 1997
Date of Patent:
July 20, 1999
Assignee:
The Council of Scientifiic and Industrial Research